Edgewise Therapeutics, Inc. (EWTX)

Import this data to Google Sheets with:

=jivedata("EWTX","financials")

Full statements spill as a table. For one cell: =jivedata("EWTX","Revenue") or =jivedata("EWTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Edgewise Therapeutics, Inc.

EWTX • CIK 0001710072

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$90,905	$126,966	$151,389	$171,273
General and Administrative Expense	$23,452	$31,866	$40,017	$47,622
Operating Income (Loss)	$-114,357	$-158,832	$-191,406	$-218,895
Operating Expenses	$114,357	$158,832	$191,406	$218,895
Net Income (Loss) Attributable to Parent	$-100,163	$-133,813	$-167,795	$-197,222
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-98,709	$-133,492	$-167,538	$-197,926
Weighted Average Number of Shares Outstanding, Basic	63,723,600	92,414,626	102,930,744	110,263,140
Interest Income, Other	$14,194	$25,019	$23,611	$21,673
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$1,454	$321	$257	$-704

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$86,097	$41,666	$61,148	$72,319
Marketable Securities	$232,296	$428,504	$468,961	$388,390
Property, Plant and Equipment, Net	$10,443	$9,503	$7,831	$6,892
Prepaid Expense and Other Assets, Current	$8,604	$5,313	$13,276	$6,445
Operating Lease, Right-of-Use Asset	$2,247	$1,569	$1,387	$1,278
Assets, Current	$326,997	$475,483	$543,385	$471,518
Other Assets, Noncurrent	$348	$262	$262	$695
Assets	$340,035	$486,817	$552,603	$479,688
Operating Lease, Liability, Noncurrent	$4,434	$3,741	$2,976	$2,569
Liabilities	$21,205	$27,601	$30,346	$31,611
Accounts Payable, Current	$4,025	$5,579	$6,006	$4,666
Employee-related Liabilities, Current	$5,695	$10,056	$12,430	$8,576
Accrued Liabilities, Current	$6,071	$7,229	$7,920	$5,189
Operating Lease, Liability, Current	$980	$996	$1,014	$1,021
Liabilities, Current	$16,771	$23,860	$27,370	$29,042
Common Stock, Value, Issued	$7	$9	$10	$10
Additional Paid in Capital	$563,487	$837,363	$1,067,941	$1,101,278
Accumulated Other Comprehensive Income (Loss), Net of Tax	$99	$420	$677	$-500
Retained Earnings (Accumulated Deficit)	$-244,763	$-378,576	$-546,371	$-652,711
Stockholders' Equity Attributable to Parent	$318,830	$459,216	$522,257	$448,077
Preferred Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	70,453,342	94,838,466	106,249,579	107,776,380

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-100,163	$-133,813	$-167,795	$-197,222
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$64,104	$-44,431	$19,482	$28,915
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$86,097	$41,666	$61,148	$44,438
Depreciation	$1,551	$2,069	$2,084	$2,126
Payments to Acquire Marketable Securities	$255,866	$477,055	$527,226	$304,521
Share-based Payment Arrangement, Noncash Expense	$17,560	$24,712	$34,752	$36,037
Proceeds from Sale of Held-to-maturity Securities	—	—	$67,384	$55,500
Accretion (Amortization) of Discounts and Premiums, Investments	$9,517	$12,545	$7,665	$5,361
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities	—	—	$427,308	$415,876
Finance Lease, Right-of-Use Asset, Amortization	$181	$221	$182	$206
Payments to Acquire Property, Plant, and Equipment	$5,745	$1,312	$256	$454
Net Cash Provided by (Used in) Investing Activities	$102,886	$-184,656	$-32,790	$166,401
Increase (Decrease) in Prepaid Expense and Other Assets	$3,553	$-3,292	$7,963	$1,547
Proceeds from Issuance of Common Stock	$52,618	$239,147	$187,362	$187,362
Increase (Decrease) in Accounts Payable	$-92	$1,737	$272	$-208
Proceeds from Stock Options Exercised	$117	$9,480	$7,803	$19,776
Increase (Decrease) in Employee Related Liabilities	$1,663	$4,361	$2,374	$2,940
Payments of Debt Issuance Costs	$165	$262	$262	$262
Increase (Decrease) in Other Accrued Liabilities	$526	$1,158	$691	$5,430
Proceeds from Stock Plans	$596	$888	$923	$1,118
IncreaseDecreaseInOperatingLeaseLiability	$-104	$-220	$-748	$-781
Net Cash Provided by (Used in) Financing Activities	$53,166	$249,253	$196,088	$20,894
Net Cash Provided by (Used in) Operating Activities	$-91,948	$-109,028	$-143,816	$-158,380
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$1,110	$1,110	$1,110	$1,110
Capital Expenditures Incurred but Not yet Paid	$227	$44	$199	$168

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("EWTX","financials")

Full statements spill as a table. For one cell: =jivedata("EWTX","Revenue") or =jivedata("EWTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.